Humana has surged this year, yet investors who bought at the wrong moment are still underwater. Medicare Advantage growth, Star Ratings, and a looming December investor update will decide whether the rebound lasts.
| Quartal / Datum | EPS (USD) | Schätzung (USD) | Abweichung |
|---|
| Quartal / Datum | Umsatz (Mrd USD) | Schätzung (Mrd USD) | Abweichung |
|---|